Concepedia

Makito Koga

MK

Statistics

Publications

6

Citations

389

H-Index

6

Active since

2012

Affiliations

Kyoto University(Current)

The University of Texas MD Anderson Cancer Center

Japan Science and Technology Agency

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Fondazione IRCCS Istituto Nazionale dei Tumori

Makito Koga is an author at Kyoto University specializing in life sciences, cell biology, and cell signaling.

ORCID

Publications per year

2012–2024

6

Publications

6

Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial

Kanwal Raghav, Salvatore Siena, Atsuo Takashima et al. · The Lancet Oncology · 2024 · 126 citations

, , +13

Synthetic lateral inhibition governs cell-type bifurcation with robust ratios

Mitsuhiro Matsuda, Makito Koga, Knut Woltjen et al. · Nature Communications · 2015 · 92 citations · Full text

, , +15

Foxd1 is a mediator and indicator of the cell reprogramming process

Makito Koga, Mitsuhiro Matsuda, Teruhisa Kawamura et al. · Nature Communications · 2014 · 78 citations · Full text

, , +9

Synthetic Signal Propagation Through Direct Cell-Cell Interaction

Mitsuhiro Matsuda, Makito Koga, Eisuke Nishida et al. · Science Signaling · 2012 · 52 citations

, , +17

HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01

Salvatore Siena, Kanwal Raghav, Toshiki Masuishi et al. · Nature Communications · 2024 · 27 citations · Full text

, , +17

1–5 of 6